Clearstead Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.62M | Sell |
9,347
-32
| -0.3% | -$8.41K | 0.02% | 341 |
|
|
2026
Q1 | $2.5M | Buy |
9,379
+64
| +0.7% | +$17.3K | 0.02% | 321 |
|
|
2025
Q4 | $2.34M | Sell |
9,315
-361
| -4% | -$95.9K | 0.03% | 304 |
|
|
2025
Q3 | $2.78M | Buy |
9,676
+249
| +3% | +$66.7K | 0.04% | 270 |
|
|
2025
Q2 | $2.47M | Sell |
9,427
-644
| -6% | -$157K | 0.03% | 282 |
|
|
2025
Q1 | $2.34M | Sell |
10,071
-48,194
| -83% | -$11.7M | 0.04% | 271 |
|
|
2024
Q4 | $13.4M | Buy |
58,265
+1,874
| +3% | +$430K | 0.2% | 105 |
|
|
2024
Q3 | $12.6M | Buy |
56,391
+16
| +0% | +$3.52K | 0.2% | 111 |
|
|
2024
Q2 | $11.5M | Buy |
56,375
+53,040
| +1,590% | +$10.8M | 0.2% | 107 |
|
|
2024
Q1 | $702K | Buy |
3,335
+593
| +22% | +$131K | 0.03% | 269 |
|
|
2023
Q4 | $623K | Sell |
2,742
-2,930
| -52% | -$615K | 0.03% | 286 |
|
|
2023
Q3 | $1.14M | Buy |
5,672
+2,371
| +72% | +$500K | 0.03% | 284 |
|
|
2023
Q2 | $684K | Buy |
3,301
+21
| +0.6% | +$4.07K | 0.04% | 254 |
|
|
2023
Q1 | $647K | Hold |
3,280
| – | – | 0.05% | 226 |
|
|
2022
Q4 | $664K | Buy |
3,280
+116
| +4% | +$22.7K | 0.05% | 212 |
|
|
2022
Q3 | $557K | Buy |
3,164
+147
| +5% | +$30.1K | 0.05% | 208 |
|
|
2022
Q2 | $608K | Buy |
3,017
+343
| +13% | +$73.1K | 0.05% | 226 |
|
|
2022
Q1 | $606K | Buy |
2,674
+200
| +8% | +$47K | 0.04% | 239 |
|
|
2021
Q4 | $668K | Buy |
2,474
+297
| +14% | +$73.5K | 0.05% | 219 |
|
|
2021
Q3 | $526K | Sell |
2,177
-8
| -0.4% | -$2.02K | 0.04% | 231 |
|
|
2021
Q2 | $518K | Buy |
2,185
+8
| +0.4% | +$1.82K | 0.04% | 226 |
|
|
2021
Q1 | $477K | Sell |
2,177
-47
| -2% | -$9.43K | 0.04% | 221 |
|
|
2020
Q4 | $389K | Sell |
2,224
-39
| -2% | -$6.74K | 0.04% | 232 |
|
|
2020
Q3 | $366K | Buy |
2,263
+48
| +2% | +$7.61K | 0.04% | 218 |
|
|
2020
Q2 | $316K | Buy |
2,215
+376
| +20% | +$52K | 0.04% | 221 |
|
|
2020
Q1 | $200K | Hold |
1,839
| – | – | 0.03% | 239 |
|
|
2019
Q4 | $267K | Sell |
1,839
-661
| -26% | -$95.4K | 0.03% | 241 |
|
|
2019
Q3 | $361K | Buy |
2,500
+384
| +18% | +$56K | 0.05% | 197 |
|
|
2019
Q2 | $314K | Hold |
2,116
| – | – | 0.04% | 212 |
|
|
2019
Q1 | $278K | Buy |
2,116
+248
| +13% | +$30.6K | 0.04% | 222 |
|
|
2018
Q4 | $203K | Buy |
+1,868
| New | +$250K | 0.03% | 240 |
|
Other funds holding LH
Clearstead Advisors's LH Position: Q2 2026 in Review
Clearstead Advisors reduced its Labcorp (LH) stake by 0.34% in Q2 2026, selling an estimated $8.41K and leaving 9,347 shares worth $2.62M. The position accounts for 0.02% of the portfolio, ranked #341.
Clearstead Advisors first reported a position in LH in Q4 2018 and has held it in 31 quarters since. The position peaked at $13.4M in Q4 2024. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Clearstead Advisors held 9,347 shares of Labcorp worth $2.62M as of Q2 2026.
- Clearstead Advisors sold 32 Labcorp shares in Q2 2026, an estimated $8.41K.
- Labcorp made up 0.02% of Clearstead Advisors's portfolio in Q2 2026, its #341 holding.
- Clearstead Advisors first reported a position in Labcorp in Q4 2018 and has held it in 31 quarters since.
- Clearstead Advisors's Labcorp position peaked at $13.4M in Q4 2024.
- 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.